Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$15,345,887
-$2,847,054 QoQ
Shares Held
121,465
-6.9% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#363
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ancora Advisors LLC holds $96,816,715 across 11 Drug Manufacturers - General names. GILD ranks #2 (15.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
229,968 | $58,404,972 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
121,465 | $15,345,887 | |
| 3 | AMGN |
Amgen Inc
|
34,637 | $12,542,749 | |
| 4 | LLY |
ELI LILLY & Co
|
3,182 | $3,816,586 | |
| 5 | MRK |
Merck & Co., Inc.
|
20,902 | $2,685,906 | |
| 6 | PFE |
Pfizer Inc
|
88,780 | $2,137,822 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
24,068 | $1,386,797 | |
| 8 | NVS |
Novartis AG
|
2,086 | $326,917 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,345,887 | 121,465 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $18,192,941 | 130,537 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $524,590 | 4,274 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $317,016 | 2,856 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $338,042 | 3,049 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $341,304 | 3,046 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $281,081 | 3,043 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $279,941 | 3,339 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $251,798 | 3,670 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $275,932 | 3,767 | Shares | Sole | 2024-05-16 | |
| 2023-12-31 | $322,662 | 3,983 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $322,092 | 4,298 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $326,314 | 4,234 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $350,050 | 4,219 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $361,085 | 4,206 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $263,663 | 4,274 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $312,573 | 5,057 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $299,687 | 5,041 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $350,270 | 4,824 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $280,028 | 4,009 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $327,911 | 4,762 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $337,562 | 5,223 | Shares | Sole | 2021-11-12 | |
| 2020-12-31 | $301,961 | 5,183 | Shares | Sole | 2021-11-12 | |
| 2020-09-30 | $353,421 | 5,593 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $504,341 | 6,555 | Shares | Sole | 2021-11-12 | |
| 2020-03-31 | $451,625 | 6,041 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||